What is Conduit Pharmaceuticals Receivables Turnover?
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Conduit Pharmaceuticals's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil. Conduit Pharmaceuticals's average Accounts Receivable for the
three
months ended in Mar. 2024 was $0.00 Mil.
Conduit Pharmaceuticals Receivables Turnover Historical Data
The historical data trend for Conduit Pharmaceuticals's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Conduit Pharmaceuticals's Receivables Turnover
For the Biotechnology subindustry, Conduit Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conduit Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Conduit Pharmaceuticals's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Conduit Pharmaceuticals's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Conduit Pharmaceuticals Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Conduit Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Conduit Pharmaceuticals (Conduit Pharmaceuticals) Business Description
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDT has been successfully added to your